Name: Name:N,N-Diethyl-4-iodobenzamide
Brand: AABLOCKS
SKU: AA005NMG
Rating: 90 (10 reviews)

Technical Information

Catalog Number: AA005NMG

Chemical Name: N,N-Diethyl-4-iodobenzamide

CAS Number: 77350-52-8

Molecular Formula: C11H14INO

Molecular Weight: 303.1394

MDL Number: MFCD02217872

SMILES: CCN(C(=O)c1ccc(cc1)I)CC

Properties

Form: Solid

Storage: 2-8℃;

Complexity: 184

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 14

Hydrogen Bond Acceptor Count: 1

Hydrogen Bond Donor Count: 0

Isotope Atom Count: 0

Rotatable Bond Count: 3

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

XLogP3: 1.9

Downstream Synthesis Route

81745-86-0

77350-52-8

130447-19-7

[1]Amatore,Christian;Jutand,Anny;Negri,Serge;Fauvarque,Jean-Francois[JournalofOrganometallicChemistry,1990,vol.390,#3,p.389-398]

77350-52-8

5713-61-1

130447-17-5

[1]Amatore,Christian;Jutand,Anny;Negri,Serge;Fauvarque,Jean-Francois[JournalofOrganometallicChemistry,1990,vol.390,#3,p.389-398]

109-89-7

1711-02-0

77350-52-8

[1]Wolfe,JohnP.;Buchwald,StephenL.[JournalofOrganicChemistry,1996,vol.61,#3,p.1133-1135]

[2]Gryf-Keller,Adam;Terpinski,Jacek;Zajaczkowska-Terpinska,Ewa[PolishJournalofChemistry,1980,vol.54,#7/8,p.1465-1471]

[3]CurrentPatentAssignee:ASTRAZENECAPLC-WO2004/41801,2004,A1Locationinpatent:Page36-37

[4]CurrentPatentAssignee:ASTRAZENECAPLC-US5691349,1997,A

[5]CurrentPatentAssignee:EqtPartnersAB;Galderma(in:EQTPartners)-US5716624,1998,A

[6]CurrentPatentAssignee:ASTRAZENECAPLC-WO2006/91160,2006,A1Locationinpatent:Page/Pagecolumn13;24

[7]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US4990505,1991,A

[8]Wallinder,Charlotta;Botros,Milad;Rosenström,Ulrika;Guimond,Marie-Odile;Beaudry,Hélène;Nyberg,Fred;Gallo-Payet,Nicole;Hallberg,Anders;Alterman,Mathias[BioorganicandMedicinalChemistry,2008,vol.16,#14,p.6841-6849]

[9]CurrentPatentAssignee:ASTRAZENECAPLC-WO2004/41800,2004,A1Locationinpatent:Page30

[10]CurrentPatentAssignee:ASTRAZENECAPLC-WO2004/41802,2004,A1Locationinpatent:Page35

[11]CurrentPatentAssignee:ASTRAZENECAPLC-WO2005/66148,2005,A1Locationinpatent:Page/Pagecolumn33

[12]CurrentPatentAssignee:ASTRAZENECAPLC;BROWNWILLAM-US2006/30569,2006,A1Locationinpatent:Page/Pagecolumn14

[13]CurrentPatentAssignee:ASTRAZENECAPLC-WO2011/65905,2011,A1Locationinpatent:Page/Pagecolumn55-56

[14]Sargent,BrendonT.;Alexanian,ErikJ.[JournaloftheAmericanChemicalSociety,2016,vol.138,#24,p.7520-7523]

111-26-2

77350-52-8

N,N-Diethyl-4-hexylamino-benzamide

[1]Wolfe,JohnP.;Buchwald,StephenL.[JournalofOrganicChemistry,1997,vol.62,#17,p.6066-6068]

[2]Wolfe,JohnP.;Buchwald,StephenL.[JournalofOrganicChemistry,1996,vol.61,#3,p.1133-1135]

77350-52-8

162883-19-4

4-((3R,5R,8R,9S,10S,13S,14S,17S)-17-Acetyl-3-hydroxy-10,13-dimethyl-hexadecahydro-cyclopentaaphenanthren-3-ylethynyl)-N,N-diethyl-benzamide

[1]Upasani,RavindraB.;Yang,KevinC.;Acosta-Burruel,Manuel;Konkoy,ChrisS.;McLellan,JamesA.;Woodward,RichardM.;Lan,NancyC.;Carter,RichardB.;Hawkinson,JonE.[JournalofMedicinalChemistry,1997,vol.40,#1,p.73-84]

Literature fold

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

77350-52-8 | N,N-Diethyl-4-iodobenzamide